Radiopharm Theranostics Limited

Radiopharm Theranostics Limited

RADX - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$27.97K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Radiopharm Theranostics LimitedRadiopharm Theranostics Limited-0.3----

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$27,971.00
Enterprise Value$-4,110,337.00
Earnings per Share$-4.56
Beta0.8
Outstanding Shares39,390

Return

Return on EquityNaN%ROE
Return on AssetsNaN%
Return on Invested CapitalNaN%

Valuation & Multiples

P/E Ratio-0.26P/E Ratio
PEG-PEG
Price to Sales-Price to Sales
Price to Book Ratio0.0Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-
Enterprise Value to Net Income-
Total Debt to Enterprise0
Debt to Equity0Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
August 28, 2026
EPS
-$1.20
Est. -$1.67
Revenue
$699,250
Est. $845,235

Next Earnings Call

Expected Date
February 26, 2027
EPS Estimate
-$1.05
Consensus analyst estimate
Revenue Estimate
$699,250
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %130.25%▼ 129662.43%
Total Invested$83,116▼ 93.01%
Investors Holding4▼ 3.00%

About Radiopharm Theranostics Limited

14 employees
CEO: Riccardo Canevari

Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs. The company d...